Crossmark

Use of New Tobacco and Nicotine Products as a Harm Reduction Strategy: A Critical Review of the Evidence

Crossref DOI link: https://doi.org/10.1016/j.opresp.2025.100534

Published Print: 2026-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Jimenez-Ruiz, Carlos Andrés

de Granda-Orive, José Ignacio

Rábade Castedo, Carlos

Farber, Harold J.

Ocampo, Angélica

Luhning, Susana

Raboso-Moreno, Beatriz

del Puerto-Garcia, Lola

Buljubasich, Daniel

Pacheco-Gallego, Manuel Conrado

Castillo-Vizueta, José Antonio

Mirambeaux-Villalona, Rosa

García-Rueda, Marcos

Riesco-Miranda, Juan Antonio

Ramos-Pinedo, Ángela

Signes-Costa, Jaime

Blanquicett-Barrios, Ledys

de Higes-Martinez, Eva

Casillas-Suarez, Catalina

Rodríguez-García, Concepción

Villar-Laguna, Cristina

Francisco-Corral, Gloria

Pastor-Esplá, Esther

Vaquero-Lozano, Paz

Carrion-Valero, Francisco

Cañón-Barroso, Lourdes

Sandoval-Contreras, Raúl

Gorordo-Unzueta, Inmaculada

Pitti-Pérez, Ruth

Muñoz-Vidal, María Ángeles

Calvo-Pascual, Susana

Cabrera-Cesar, Eva

Díaz-Santos, Germán

Cristóbal-Fernández, Maribel
Funding

Funding for this research was provided by:

Pfizer

Novartis
License Information

Text and Data Mining valid from 2026-04-01

Text and Data Mining valid from 2026-04-01

Version of Record valid from 2025-12-22
More Information

This article is maintained by: Elsevier

Article Title: Use of New Tobacco and Nicotine Products as a Harm Reduction Strategy: A Critical Review of the Evidence

Journal Title: Open Respiratory Archives

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.opresp.2025.100534

Content Type: article

Copyright: © 2026 Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below